Literature DB >> 19444714

Development and initial validation of a measure of perceived stigma in irritable bowel syndrome.

Michael P Jones1, Laurie Keefer, Jason Bratten, Tiffany H Taft, Michael D Crowell, Rona Levy, Olafur Palsson.   

Abstract

Irritable bowel syndrome (IBS) is a poorly understood digestive disorder prone to stigmatization. We developed a measure of condition-specific perceived stigma to better understand the role of stigma in this common disorder. Questionnaire items were established through structured patient interviews. A 10-item measure assessing relevant stigma variables across social domains was then administered to 148 patients with IBS. Test-retest reliability was assessed by having a subset of 26 patients re-complete the measure after 2 weeks. Twenty-eight out of 49 (57%) interview subjects with some degree of perceived stigma related to their IBS. A 10-item measure was developed with the following areas of perceived stigmatization: limited disclosure of IBS; belief that public knowledge about IBS was low; feeling that IBS was not taken seriously; people implying that IBS symptoms are self-inflicted; role limitations because of IBS; and others having the belief that IBS is 'all in their head'. Respondents rated the 10 items on the new measure with respect to perceived stigma in the social domains of healthcare providers; spouses/significant others; family members; friends; boss/supervisor; and coworkers/classmates. Stigma scores were significantly correlated with scores from the modified HIV stigma instrument (r = 0.56; p < 0.0001). Cronbach's alpha was estimated at 0.91. Mean inter-item correlation was 0.50 and ranged from 0.29 to 0.71. Guttman's split-half reliability coefficient was estimated at 0.89. Test-retest reliability was high (r = 0.91; p < 0.0001). Patients with IBS reported the greatest degrees of perceived stigma related to coworkers, employers, and friends. Stigma dimensions which received the highest scores focused upon limited knowledge of IBS by others along with a lack of interest or understanding of others towards the condition. The IBS perceived stigma scale is a reliable, valid measure of perceived stigma related to IBS.

Entities:  

Mesh:

Year:  2009        PMID: 19444714     DOI: 10.1080/13548500902865956

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  15 in total

Review 1.  Development of an online library of patient-reported outcome measures in gastroenterology: the GI-PRO database.

Authors:  Puja Khanna; Nikhil Agarwal; Dinesh Khanna; Ron D Hays; Lin Chang; Roger Bolus; Gil Melmed; Cynthia B Whitman; Robert M Kaplan; Rikke Ogawa; Bradley Snyder; Brennan Mr Spiegel
Journal:  Am J Gastroenterol       Date:  2013-12-17       Impact factor: 10.864

2.  Understanding gastrointestinal distress: a framework for clinical practice.

Authors:  Brennan M R Spiegel; Dinesh Khanna; Roger Bolus; Nikhil Agarwal; Puja Khanna; Lin Chang
Journal:  Am J Gastroenterol       Date:  2011-03       Impact factor: 10.864

3.  Stigma perceptions in patients with eosinophilic gastrointestinal disorders.

Authors:  L Guadagnoli; T H Taft; L Keefer
Journal:  Dis Esophagus       Date:  2017-07-01       Impact factor: 3.429

4.  Validation of the Health-Related Felt Stigma and Concealment Questionnaire.

Authors:  Kelsey T Laird; Craig A Smith; Steven D Hollon; Lynn S Walker
Journal:  J Pediatr Psychol       Date:  2020-06-01

5.  Perceptions of illness stigma in patients with inflammatory bowel disease and irritable bowel syndrome.

Authors:  Tiffany H Taft; Laurie Keefer; Caroline Artz; Jason Bratten; Michael P Jones
Journal:  Qual Life Res       Date:  2011-03-20       Impact factor: 4.147

Review 6.  Natural polyphenols for the prevention of irritable bowel syndrome: molecular mechanisms and targets; a comprehensive review.

Authors:  Nazanin Momeni Roudsari; Naser-Aldin Lashgari; Saeideh Momtaz; Mohammad Hosein Farzaei; André M Marques; Amir Hossein Abdolghaffari
Journal:  Daru       Date:  2019-07-04       Impact factor: 3.117

7.  Impact of perceived stigma on inflammatory bowel disease patient outcomes.

Authors:  Tiffany H Taft; Laurie Keefer; Christoph Leonhard; Michele Nealon-Woods
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

Review 8.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  Stigmatization toward irritable bowel syndrome and inflammatory bowel disease in an online cohort.

Authors:  T H Taft; A Bedell; J Naftaly; L Keefer
Journal:  Neurogastroenterol Motil       Date:  2016-08-08       Impact factor: 3.598

10.  Patient-reported outcomes in gastroenterology: clinical and research applications.

Authors:  Brennan M R Spiegel
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.